Listed Funds Trust has filed its latest NPORT-P report, which provides a detailed overview of its assets and liabilities as of August 31, 2026. This filing is crucial as it reflects the company's ongoing commitment to transparency and regulatory compliance in the investment sector.
The report shows that Listed Funds Trust has total assets amounting to approximately $944.9 million, with total liabilities reported at around $401,058. This results in net assets of approximately $944.5 million. Such figures are significant as they provide insight into the fund's financial health and operational efficiency.
Founded in Milwaukee, Wisconsin, Listed Funds Trust is categorized under the investment entity type. The company has undergone a name change from Active Weighting Funds ETF Trust to its current name, reflecting its strategic focus on managing investment portfolios effectively.
According to the filing, the fund's performance has seen fluctuations, with monthly total returns showing a decline of 2.15% and 2.23% in two of the preceding months, followed by a positive return of 3.90% in the most recent month. This performance data is critical for investors assessing the fund's viability and potential for growth.
The filing also highlights the fund's investment strategy, which includes notable holdings in major corporations such as Gilead Sciences Inc, Johnson & Johnson, and Merck & Co Inc. These investments contribute to the fund's overall asset allocation and risk profile.
Investors and stakeholders will be particularly interested in how these assets are managed and the implications for future returns. The filing indicates that the fund does not have any outstanding debts or obligations to banks or affiliated companies, which positions it favorably in terms of financial stability.
The investment industry is keenly observing Listed Funds Trust's performance as it navigates the complexities of market fluctuations. Competitors will likely analyze this report to gauge their strategies and positioning within the sector.
Looking ahead, the filing does not specify what actions will follow this report, leaving stakeholders to anticipate future updates and potential changes in strategy or management.